NASDAQ:JANX | Insider Transactions | Janux Therapeutics, Inc.

JANX Insider Transactions

309 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.

JANX insiders transaction timeline

PurchaseSale
2021-06-15: 21 purchases — Bregua Corp, Thompson Peter A., ORBIMED ADVISORS LLC and 10 more2021-12-16: 8 sales — Thompson Peter A., ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC and 1 more2021-12-21: 8 sales — ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Capital GP VIII LLC and 1 more2021-12-29: 8 sales — ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Capital GP VIII LLC and 1 more2023-07-19: 5 purchases — RA Capital Healthcare Fund LP, RA CAPITAL MANAGEMENT, L.P., Kolchinsky Peter and 2 more2023-11-13: 5 purchases — Reardon Tighe, Lichter Jay, Avalon Ventures XI, L.P. and 2 more2024-06-03: 14 sales — Lichter Jay, Reardon Tighe, Avalon Ventures XI, L.P. and 2 more2024-09-06: 12 sales — Lichter Jay, Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P. and 1 more2024-09-09: 4 sales — Lichter Jay, Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P. and 1 more2024-09-10: 24 sales — Lichter Jay, Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P. and 1 more2024-09-12: 12 sales — Lichter Jay, Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P. and 1 more2024-09-13: 1 sale — Lichter Jay2024-09-26: 24 sales — Lichter Jay, Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P. and 1 more2024-09-27: 34 sales — Lichter Jay, Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P. and 4 more2024-09-30: 4 sales — Lichter Jay, Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P. and 1 more2024-10-16: 28 sales — Lichter Jay, Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P. and 1 more2024-10-17: 4 sales — Lichter Jay, Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P. and 1 more2024-10-18: 5 purchases — RA Capital Healthcare Fund LP, RA CAPITAL MANAGEMENT, L.P., Kolchinsky Peter and 2 more2024-10-18: 36 sales — Lichter Jay, Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P. and 1 more2024-10-28: 2 sales — Campbell David Alan2024-11-25: 2 sales — Campbell David Alan2024-12-03: 1 sale — Campbell David Alan2024-12-24: 1 sale — Campbell David Alan2025-01-02: 5 sales — Meyer Andrew Hollman2025-01-07: 1 sale — Campbell David Alan2025-02-03: 3 sales — Meyer Andrew Hollman2025-03-03: 2 sales — Meyer Andrew Hollman2025-03-05: 10 purchases — RA Capital Healthcare Fund LP, RA CAPITAL MANAGEMENT, L.P., Kolchinsky Peter and 2 more2025-03-06: 5 purchases — RA Capital Healthcare Fund LP, RA CAPITAL MANAGEMENT, L.P., Kolchinsky Peter and 2 more2025-03-07: 5 purchases — RA Capital Healthcare Fund LP, RA CAPITAL MANAGEMENT, L.P., Kolchinsky Peter and 2 more2025-04-21: 1 sale — Meyer Andrew Hollman2025-05-01: 2 sales — Meyer Andrew Hollman2025-10-28: 1 sale — Meyer Andrew Hollman2025-11-14: 1 sale — Meyer Andrew Hollman2025-12-01: 2 sales — Meyer Andrew Hollman2026-01-02: 6 sales — McIver Zachariah, Dobek Maria, DiRaimondo Thomas and 3 more2026-05-11: 1 sale — Dobek Maria2026-06-02: 1 sale — Doyle Janeen Noel2021-06-152026-06-02
Insider profileRoleDateTransactionSharesPrice
Doyle Janeen NoelChief Corp. & Bus. Dev. Ofcr2026-06-02Sale4,059.0$14.03
Dobek MariaVice President, Accounting2026-05-11Sale2,038.0$14.17
McIver ZachariahChief Medical Officer2026-01-02Sale2,714.0$13.73
Dobek MariaVice President, Accounting2026-01-02Sale1,462.0$13.73
DiRaimondo ThomasChief Scientific Officer2026-01-02Sale2,505.0$13.73
Winter Charles M.Chief Technical Officer2026-01-02Sale2,401.0$13.73
Meyer Andrew HollmanChief Business Officer2026-01-02Sale1,879.0$13.73
Campbell David AlanPresident and CEO2026-01-02Sale8,072.0$13.73
Meyer Andrew HollmanChief Business Officer2025-12-01Sale633.0$33.52
Meyer Andrew HollmanChief Business Officer2025-12-01Sale2,700.0$32.85
Meyer Andrew HollmanChief Business Officer2025-11-14Sale3,333.0$30.0
Meyer Andrew HollmanChief Business Officer2025-10-28Sale16,665.0$30.06
Meyer Andrew HollmanChief Business Officer2025-05-01Sale400.0$32.6
Meyer Andrew HollmanChief Business Officer2025-05-01Sale2,933.0$31.95
Meyer Andrew HollmanChief Business Officer2025-04-21Sale3,334.0$30.0
RA Capital Healthcare Fund LPDirector,TenPercentOwner2025-03-07Purchase110,206.0$31.02
RA CAPITAL MANAGEMENT, L.P.Director,TenPercentOwner2025-03-07Purchase110,206.0$31.02
Kolchinsky PeterDirector,TenPercentOwner2025-03-07Purchase110,206.0$31.02
Shah Rajeev M.Director,TenPercentOwner2025-03-07Purchase110,206.0$31.02
RA Capital Nexus Fund II, L.P.Director2025-03-07Purchase110,206.0$31.02
RA Capital Healthcare Fund LPDirector,TenPercentOwner2025-03-06Purchase372,093.0$30.78
RA CAPITAL MANAGEMENT, L.P.Director,TenPercentOwner2025-03-06Purchase372,093.0$30.78
Kolchinsky PeterDirector,TenPercentOwner2025-03-06Purchase372,093.0$30.78
Shah Rajeev M.Director,TenPercentOwner2025-03-06Purchase372,093.0$30.78
RA Capital Nexus Fund II, L.P.Director2025-03-06Purchase372,093.0$30.78
RA Capital Healthcare Fund LPDirector,TenPercentOwner2025-03-05Purchase37,455.0$31.3
RA CAPITAL MANAGEMENT, L.P.Director,TenPercentOwner2025-03-05Purchase37,455.0$31.3
Kolchinsky PeterDirector,TenPercentOwner2025-03-05Purchase37,455.0$31.3
Shah Rajeev M.Director,TenPercentOwner2025-03-05Purchase37,455.0$31.3
RA Capital Nexus Fund II, L.P.Director2025-03-05Purchase37,455.0$31.3
RA Capital Healthcare Fund LPDirector,TenPercentOwner2025-03-05Purchase304,287.0$30.56
RA CAPITAL MANAGEMENT, L.P.Director,TenPercentOwner2025-03-05Purchase304,287.0$30.56
Kolchinsky PeterDirector,TenPercentOwner2025-03-05Purchase304,287.0$30.56
Shah Rajeev M.Director,TenPercentOwner2025-03-05Purchase304,287.0$30.56
RA Capital Nexus Fund II, L.P.Director2025-03-05Purchase304,287.0$30.56
Meyer Andrew HollmanChief Business Officer2025-03-03Sale901.0$32.85
Meyer Andrew HollmanChief Business Officer2025-03-03Sale2,433.0$31.88
Meyer Andrew HollmanChief Business Officer2025-02-03Sale100.0$43.6
Meyer Andrew HollmanChief Business Officer2025-02-03Sale816.0$42.77
Meyer Andrew HollmanChief Business Officer2025-02-03Sale2,418.0$42.08
Campbell David AlanPresident and CEO2025-01-07Sale5,000.0$60.0
Meyer Andrew HollmanChief Business Officer2025-01-02Sale200.0$57.37
Meyer Andrew HollmanChief Business Officer2025-01-02Sale1,000.0$56.78
Meyer Andrew HollmanChief Business Officer2025-01-02Sale3,444.0$55.76
Meyer Andrew HollmanChief Business Officer2025-01-02Sale5,768.0$54.51
Meyer Andrew HollmanChief Business Officer2025-01-02Sale2,922.0$53.76
Campbell David AlanPresident and CEO2024-12-24Sale25,000.0$56.19
Campbell David AlanPresident and CEO2024-12-03Sale15,000.0$67.0
Campbell David AlanPresident and CEO2024-11-25Sale6,719.0$52.04
Campbell David AlanPresident and CEO2024-11-25Sale18,281.0$51.43
Campbell David AlanPresident and CEO2024-10-28Sale11,103.0$53.94
Campbell David AlanPresident and CEO2024-10-28Sale13,897.0$53.22
RA Capital Healthcare Fund LPDirector,TenPercentOwner2024-10-18Purchase1,200,000.0$44.75
RA CAPITAL MANAGEMENT, L.P.Director,TenPercentOwner2024-10-18Purchase1,200,000.0$44.75
Kolchinsky PeterDirector,TenPercentOwner2024-10-18Purchase1,200,000.0$44.75
Shah Rajeev M.Director,TenPercentOwner2024-10-18Purchase1,200,000.0$44.75
RA Capital Nexus Fund II, L.P.Director2024-10-18Purchase1,200,000.0$44.75
Lichter JayTenPercentOwner2024-10-18Sale553,219.0$44.75
Avalon Ventures XI, L.P.TenPercentOwner2024-10-18Sale553,219.0$44.75
Avalon BioVentures SPV I, L.P.TenPercentOwner2024-10-18Sale553,219.0$44.75
Avalon BioVentures I, LPTenPercentOwner2024-10-18Sale553,219.0$44.75
Lichter JayTenPercentOwner2024-10-18Sale104,957.0$44.75
Avalon Ventures XI, L.P.TenPercentOwner2024-10-18Sale104,957.0$44.75
Avalon BioVentures SPV I, L.P.TenPercentOwner2024-10-18Sale104,957.0$44.75
Avalon BioVentures I, LPTenPercentOwner2024-10-18Sale104,957.0$44.75
Lichter JayTenPercentOwner2024-10-18Sale541,824.0$44.75
Avalon Ventures XI, L.P.TenPercentOwner2024-10-18Sale541,824.0$44.75
Avalon BioVentures SPV I, L.P.TenPercentOwner2024-10-18Sale541,824.0$44.75
Avalon BioVentures I, LPTenPercentOwner2024-10-18Sale541,824.0$44.75
Lichter JayTenPercentOwner2024-10-18Sale15,788.0$51.18
Avalon Ventures XI, L.P.TenPercentOwner2024-10-18Sale15,788.0$51.18
Avalon BioVentures SPV I, L.P.TenPercentOwner2024-10-18Sale15,788.0$51.18
Avalon BioVentures I, LPTenPercentOwner2024-10-18Sale15,788.0$51.18
Lichter JayTenPercentOwner2024-10-18Sale2,995.0$51.18
Avalon Ventures XI, L.P.TenPercentOwner2024-10-18Sale2,995.0$51.18
Avalon BioVentures SPV I, L.P.TenPercentOwner2024-10-18Sale2,995.0$51.18
Avalon BioVentures I, LPTenPercentOwner2024-10-18Sale2,995.0$51.18
Lichter JayTenPercentOwner2024-10-18Sale15,462.0$51.18
Avalon Ventures XI, L.P.TenPercentOwner2024-10-18Sale15,462.0$51.18
Avalon BioVentures SPV I, L.P.TenPercentOwner2024-10-18Sale15,462.0$51.18
Avalon BioVentures I, LPTenPercentOwner2024-10-18Sale15,462.0$51.18
Lichter JayTenPercentOwner2024-10-18Sale104,892.0$50.3
Avalon Ventures XI, L.P.TenPercentOwner2024-10-18Sale104,892.0$50.3
Avalon BioVentures SPV I, L.P.TenPercentOwner2024-10-18Sale104,892.0$50.3
Avalon BioVentures I, LPTenPercentOwner2024-10-18Sale104,892.0$50.3
Lichter JayTenPercentOwner2024-10-18Sale19,900.0$50.3
Avalon Ventures XI, L.P.TenPercentOwner2024-10-18Sale19,900.0$50.3
Avalon BioVentures SPV I, L.P.TenPercentOwner2024-10-18Sale19,900.0$50.3
Avalon BioVentures I, LPTenPercentOwner2024-10-18Sale19,900.0$50.3
Lichter JayTenPercentOwner2024-10-18Sale102,732.0$50.3
Avalon Ventures XI, L.P.TenPercentOwner2024-10-18Sale102,732.0$50.3
Avalon BioVentures SPV I, L.P.TenPercentOwner2024-10-18Sale102,732.0$50.3
Avalon BioVentures I, LPTenPercentOwner2024-10-18Sale102,732.0$50.3
Lichter JayTenPercentOwner2024-10-17Sale1,843.0$50.02
Avalon Ventures XI, L.P.TenPercentOwner2024-10-17Sale1,843.0$50.02
Avalon BioVentures SPV I, L.P.TenPercentOwner2024-10-17Sale1,843.0$50.02
Avalon BioVentures I, LPTenPercentOwner2024-10-17Sale1,843.0$50.02
Lichter JayTenPercentOwner2024-10-16Sale10,957.0$50.8
Avalon Ventures XI, L.P.TenPercentOwner2024-10-16Sale10,957.0$50.8
Avalon BioVentures SPV I, L.P.TenPercentOwner2024-10-16Sale10,957.0$50.8